|
Krikun, G; Schatz, F; Mackman, N et al. (1998) Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells. J Clin Endocrinol Metab 83:926-30
|
|
Lockwood, C J; Krikun, G; Hausknecht, V A et al. (1998) Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinology 139:4607-13
|
|
Schatz, F; Papp, C; Aigner, S et al. (1997) Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression. J Clin Endocrinol Metab 82:188-93
|
|
Arcuri, F; Battistini, S; Hausknecht, V et al. (1997) Human endometrial decidual cell-associated 11 beta-hydroxysteroid dehydrogenase expression: its potential role in implantation. Early Pregnancy 3:259-64
|
|
Arcuri, F; Monder, C; Lockwood, C J et al. (1996) Expression of 11 beta-hydroxysteroid dehydrogenase during decidualization of human endometrial stromal cells. Endocrinology 137:595-600
|
|
Lockwood, C J; Schatz, F (1996) A biological model for the regulation of peri-implantational hemostasis and menstruation. J Soc Gynecol Investig 3:159-65
|
|
Schatz, F; Aigner, S; Papp, C et al. (1995) Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1. J Clin Endocrinol Metab 80:2504-10
|
|
Lockwood, C J; Krikun, G; Papp, C et al. (1994) Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content. J Clin Endocrinol Metab 79:786-90
|
